close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Health Panel

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Health Profile

Enter health info to personalize results.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Mark Amsbaugh

location-icon

Houston, TX

LOCATION OF PRACTICE
Mcgovern Medical School At Uthealth Houston
MEDICAL Specialty:

Prostate Cancer



NPI Number
1245598168
ABOUT

Dr. Mark Amsbaugh is a board-certified and fellowship-trained radiation oncologist specializing in tumors of the central nervous system, lung, head and neck, prostate, and breast.

Dr. Mark Amsbaugh profile image

Published Articles

Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation.- 2026 Mar
Patterns of failure following stereotactic radiosurgery salvage for recurrent high-grade glioma.- 2026 Mar 14
Molecular Features of Glioblastoma Isocitrate Dehydrogenase-Wildtype in Extreme Survival Groups After Supramaximal and Maximal Resection.- 2026 Jan 27
Outcome Evaluation of Volume-Staged Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations.- 2026 Jan 1
Cystic glioblastoma IDH-wildtype: genetic alterations and outcomes.- 2025 Nov
Dosimetric predictors of toxicity for brainstem metastases and AVMs treated with stereotactic radiosurgery: An international, multi-institutional analysis.- 2025 May
Comparative effectiveness of frame-based and mask-based Gamma Knife stereotactic radiosurgery in brain metastases: A 509 patient meta-analysis.- 2024 Oct
Belzutifan, HIF-2α Inhibitor, and Clear Cell Renal Cell Carcinoma With Somatic Von-Hippel-Lindau Loss-of-Function Mutation.- 2024 Jan-Dec
Medulloblastoma.- 2026 Jan
Brain Metastasis.- 2026 Jan

Clinical Trials

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases, PREEMPT Trial
Mucociliary Clearance Time in Chronic Rhinosinusitis (CRS) Patients After Sinus Surgery

My Patient Resources

Other Specialists treating Prostate Cancer in Houston, TX

See All Doctors

Dr. Eleni Efstathiou

Specialty: Bone Cancer, Thyroid Cancer, Prostate Cancer

My Resources
location-icon

Houston Methodist Hospital

My Resources

Dr. Edward Yen

Specialty: Prostate Cancer, Genitourinary Cancer

My Resources
location-icon

Baylor College of Medicine

My Resources

Dr. Andy Chen

Specialty: Radiation Oncology

My Resources
location-icon

Texas Oncology-Houston Medical Center

My Resources

Dr. Neha Maithel

Specialty: Genitourinary Cancers

My Resources
location-icon

Memorial Hermann Cancer Center

My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider